Identification of Campylobacter jejuni and determination of point mutations associated with macrolide resistance using a multiplex TaqMan MGB real-time PCR

Journal of Applied Microbiology
Haihong HaoZonghui Yuan

Abstract

The aim of the study was to develop a multiplex real-time PCR method to identify Campylobacter jejuni containing mutations commonly associated with macrolide resistance. A multiplex fluorescence real-time PCR assay was developed based on TaqMan minor groove binder (MGB) probes. The VS1-MGB probe was designed based on the VS1 gene and was used to identify Camp. jejuni. The 23S rDNA-MGB probe was designed to distinguish macrolide resistance mutations in 23S rDNA, while 57D-MGB and 74D-MGB were designed to detect resistance mutations in ribosomal protein L4. The specificity and accuracy of our method were identical to the conventional biochemical tests, mapA PCR, minimum inhibitory concentration (MIC) determination and DNA sequencing. The linear detection limit of the method was 0·03 ng genomic DNA and three colony formation unit (CFU) per reaction. In 6 of 18 cases, the nature of Erythromycin resistance could be correctly determined from natural isolates; absence of the tested mutations was demonstrated in the remaining four resistant isolates. A multiplex TaqMan MGB real-time PCR assay with high specificity and accuracy was developed to simultaneously identify Camp. jejuni and detect the gene mutations associated with macrolide ...Continue Reading

References

Mar 17, 2005·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sylvie VacherFrancis Megraud
Jun 1, 2006·The Journal of Antimicrobial Chemotherapy·Amera Gibreel, Diane E Taylor
Mar 14, 2007·Antimicrobial Agents and Chemotherapy·Jun LinQijing Zhang
Sep 10, 2008·Antimicrobial Agents and Chemotherapy·Dave Bryson CaldwellJun Lin
Mar 5, 2009·Future Microbiology·Taradon LuangtongkumQijing Zhang
Oct 28, 2009·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Haihong HaoZonghui Yuan
Mar 8, 2011·Microbial Pathogenesis·Yassir A AlmoftiZonghui Yuan
Aug 31, 2011·International Journal of Food Microbiology·Yassir A AlmoftiZonghui Yuan
Feb 15, 2013·Virulence·Nicole M Iovine
Jul 19, 2013·BioMed Research International·Kinga Wieczorek, Jacek Osek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Campylobacteriosis (ASM)

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.